News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Omeros Corporation, First U.S. Biotech IPO Since February 2008, Sees Shares Drop 13 Percent in First Day
October 9, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Xconomy.com -- Shares of Seattle-based Omeros, the first true U.S. biotech company to go public in more than 18 months, dropped about 13 percent in the company’s first day of trading.
Twitter
LinkedIn
Facebook
Email
Print
IPO
Omeros Corporation
MORE ON THIS TOPIC
Deals
Angelini inks $4.1B Catalyst buy to enter US rare disease market
May 7, 2026
·
2 min read
·
Gabrielle Masson
Weight loss
GSK goes beyond weight-loss with $1B buyout of Chinese siRNA specialist
May 7, 2026
·
2 min read
·
Tristan Manalac
Job Trends
Increased capital boosts biotech R&D job postings, employment
May 7, 2026
·
4 min read
·
Angela Gabriel
Manufacturing
Amgen, Sanofi commit nearly $600M to North American expansions
May 6, 2026
·
2 min read
·
Nick Paul Taylor